Tony Zook - Articles and news items


AstraZeneca announces changes to Senior Executive Team

Industry news, News / 15 January 2013 / AstraZeneca

AstraZeneca unveiled changes to its executive leadership team…


AstraZeneca and Pfizer enter agreement for over-the-counter NEXIUM; AstraZeneca raises 2012 guidance

Industry news, News / 13 August 2012 / AstraZeneca

NEXIUM 20mg retail launch targeted for 2014, subject to regulatory approval…


AstraZeneca to present new healthcare economics data demonstrating cost-effectiveness of BRILIQUE

Industry news, News / 21 October 2011 / AstraZeneca

AstraZeneca will present key results from health economics sub-studies…


AstraZeneca announces first approval of FASLODEX™ (fulvestrant) in Japan

Industry news, News / 26 September 2011 / AstraZeneca

AstraZeneca announced that FASLODEX™ (fulvestrant) has received regulatory approval…


Positive agreement received for approval of AXANUM (low-dose ASA/esomeprazole) in Europe

Industry news, News / 2 August 2011 / AstraZeneca

AstraZeneca announced that AXANUM has received positive agreement for approval…


AstraZeneca’s NEXIUM receives first regulatory approval in Japan for the treatment of acid-related diseases

Industry news, News / 1 July 2011 / AstraZeneca

NEXIUM 10 mg and 20 mg capsules have received regulatory approval in Japan…


AstraZeneca signs agreement in Japan with Daiichi Sankyo

Industry news, News / 24 May 2011 / AstraZeneca

AstraZeneca signs agreement with Daiichi Sankyo for denosumab for the treatment of bone disorders…

BRILIQUE (ticagrelor)

Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment versus generic Clopidogrel

Industry news, News / 9 May 2011 / AstraZeneca

New health economics data from a substudy of the PLATO trial…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...